Olympus Reports Decline in Q1 Financial Performance Amid Business Adjustments

Olympus ( (JP:7733) ) just unveiled an update.

Olympus Corporation reported a significant decline in its financial performance for the three months ending June 30, 2025, with revenue and profits dropping compared to the previous year. The company’s revenue fell by 12.1%, and operating profit decreased by 39.6%, largely due to the classification of its Orthopedic Business as a discontinued operation. Despite these challenges, Olympus has revised its full-year forecast, expecting minimal revenue growth but a notable decline in profits, reflecting ongoing adjustments in its business operations.

The most recent analyst rating on (JP:7733) stock is a Hold with a Yen2600.00 price target. To see the full list of analyst forecasts on Olympus stock, see the JP:7733 Stock Forecast page.

More about Olympus

Olympus Corporation operates in the medical technology industry, primarily focusing on manufacturing and selling precision machinery and instruments. The company is listed on the Prime Market of the Tokyo Stock Exchange and is known for its innovative solutions in medical, scientific, and industrial fields.

Average Trading Volume: 4,362,801

Technical Sentiment Signal: Sell

Current Market Cap: Yen2021.3B

Find detailed analytics on 7733 stock on TipRanks’ Stock Analysis page.